Nervous system diseases

Nervous system diseases

Pain Management in Dementia: A Comprehensive Review of Healthcare Personnel's Knowledge, Attitudes, and Practices

A study published in the Pain Management Nursing journal has shed light on the challenges of pain management in people with dementia, highlighting a significant knowledge-practice gap among healthcare personnel. The research involved an integrative review of 32 full-text articles, which revealed five major themes: inadequate knowledge, mixed negative and

Nervous system diseases

Potential Effectiveness of Yokukansan and Lemborexant in Preventing Benzodiazepine Withdrawal Delirium

Researchers from the National Cancer Center Hospital in Tokyo, Japan, have reported a case study and literature review highlighting the potential effectiveness of yokukansan and lemborexant as alternative candidates to benzodiazepines in preventing benzodiazepine withdrawal delirium in the cancer perioperative period. The study involved a patient who had been receiving

Nervous system diseases

Antimicrobial Treatment Ameliorates Delirium-like Phenotypes in Murine Model of Urinary Tract Infection

New research conducted at Cedars-Sinai Medical Center in Los Angeles, California, reveals that antimicrobial treatment can alleviate delirium-like symptoms in mice induced with urinary tract infections (UTI). The study, published in Translational Psychiatry, suggests that this finding could have significant implications for the treatment of delirium in humans, particularly in

RNA

H. Lundbeck A/S and Contera Pharma Form Strategic Alliance to Advance RNA-Based Therapies for Neurological Diseases

H. Lundbeck A/S, a leading Danish pharmaceutical company, and Contera Pharma, a Danish clinical-stage biotech company, have joined forces to accelerate the development of oligonucleotide-based medicines for serious neurological conditions. The strategic research collaboration leverages Lundbeck's extensive neuroscience experience and Contera Pharma's RNA discovery platforms